https://healthylivingeurope.com/article/914031575-commlab-india-ranked-among-top-3-custom-elearning-providers-globally Healthy Living Europe en PressRelease 2026-05-21T11:27:13+00:00 CommLab India Ranked Among Top 3 Custom eLearning Providers Globally https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24863334-top-custom-elearning-providers-1200x628.png https://healthylivingeurope.com/article/913630846-bone-cells-use-vitamin-k-signals-to-regulate-osteoclast-fusion Healthy Living Europe en PressRelease 2026-05-21T10:30:00+00:00 Bone Cells Use Vitamin K Signals to Regulate Osteoclast Fusion https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24861010-ijosb-54-4-602x779.jpeg https://healthylivingeurope.com/article/914005716-kfsh-spotlights-ai-s-role-in-expanding-patient-access-while-preserving-human-centered-care Healthy Living Europe en PressRelease 2026-05-21T08:39:50+00:00 KFSH Spotlights AI’s Role in Expanding Patient Access While Preserving Human-Centered Care https://healthylivingeurope.com/article/913990771-absolute-digital-media-wins-best-use-of-search-b2c-ppc-at-the-european-search-awards-2026 Healthy Living Europe en PressRelease 2026-05-21T06:35:46+00:00 Absolute Digital Media Wins Best Use of Search — B2C (PPC): At the European Search Awards 2026 https://healthylivingeurope.com/article/913871100-abl-diagnostics-drives-emea-expansion-with-vela-diagnostics-partnership Healthy Living Europe en PressRelease 2026-05-21T06:00:00+00:00 ABL Diagnostics Drives EMEA Expansion with VELA Diagnostics Partnership https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24862568-veladx-861x327.jpeg https://healthylivingeurope.com/article/913890515-how-companies-compete-in-the-energy-based-aesthetic-devices-market-insights-into-market-leadership Healthy Living Europe en PressRelease 2026-05-21T04:16:14+00:00 How Companies Compete in the Energy-Based Aesthetic Devices Market: Insights into Market Leadership https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24862700-energy-based-aesthetic-devices-1920x1080.png https://healthylivingeurope.com/article/913886471-companion-diagnostics-market-2026-firms-competing-through-innovation-and-market-reach Healthy Living Europe en PressRelease 2026-05-21T04:16:13+00:00 Companion Diagnostics Market 2026: Firms Competing Through Innovation and Market Reach https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24862688-companion-diagnostics-market-an-1920x1080.png https://healthylivingeurope.com/article/913881599-from-leaders-to-challengers-competitive-dynamics-in-the-botulinum-toxin-market Healthy Living Europe en PressRelease 2026-05-21T04:16:12+00:00 From Leaders to Challengers: Competitive Dynamics in the Botulinum Toxin Market https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24862652-botulinum-toxin-market-share-1920x1080.png https://healthylivingeurope.com/article/913875656-resuscitation-devices-market-competitive-outlook-strategic-moves-of-leading-players Healthy Living Europe en PressRelease 2026-05-21T04:16:10+00:00 Resuscitation Devices Market Competitive Outlook: Strategic Moves of Leading Players https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24862591-resuscitation-devices-market-gr-1920x1080.png https://healthylivingeurope.com/article/914016473-hanmi-pharmaceutical-partners-with-organon-to-export-combination-therapies-to-southeast-asia Healthy Living Europe en PressRelease 2026-05-21T09:06:12+00:00 Hanmi Pharmaceutical Partners with Organon to Export Combination Therapies to Southeast Asia https://ml.globenewswire.com/media/b62e29c9-0e09-4dad-9cb8-6e47fb8415db/medium/signing-ceremony-strategic-partnership-agreement-between-han.png https://healthylivingeurope.com/article/913896386-adentris-expands-ai-platform-with-five-new-modules-covering-the-full-revenue-integrity-and-compliance-workflow Healthy Living Europe en PressRelease 2026-05-20T20:41:54+00:00 Adentris Expands AI Platform with Five New Modules Covering the Full Revenue Integrity and Compliance Workflow https://healthylivingeurope.com/article/913882004-l-a-care-association-secures-500-000-grant-to-unlock-licensed-beds-for-homeless-angelenos-with-mental-illness Healthy Living Europe en PressRelease 2026-05-20T20:33:09+00:00 L.A. Care Association Secures $500,000 Grant to Unlock Licensed Beds for Homeless Angelenos With Mental Illness https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24862659-making-a-bed-1958x1300.jpeg https://healthylivingeurope.com/article/913893048-adentris-completes-major-ai-compliance-deployment-at-sobrius-putting-over-100-active-sud-patients-under-review Healthy Living Europe en PressRelease 2026-05-20T20:16:40+00:00 Adentris Completes Major AI Compliance Deployment at Sobrius, Putting Over 100 Active SUD Patients Under Review https://healthylivingeurope.com/article/914016456-concept-life-sciences-partners-with-openbench-to-deliver-success-based-drug-discovery-services-for-early-stage-biotech Healthy Living Europe en PressRelease 2026-05-21T08:00:00+00:00 Concept Life Sciences Partners with OpenBench to Deliver Success-Based Drug Discovery Services for Early-Stage Biotech https://ml.globenewswire.com/media/eceda892-09d6-4e5a-a744-6b396a975b79/small/concept-life-sciences-600x450-jpg.jpg https://healthylivingeurope.com/article/914016427-orion-pharma-to-present-its-first-clinical-data-from-phase-1-2-teades-trial-of-tead-inhibitor-odm-212-at-the-2026-asco-annual-meeting Healthy Living Europe en PressRelease 2026-05-21T07:30:00+00:00 Orion Pharma to present its first clinical data from Phase 1/2 TEADES trial of TEAD inhibitor ODM-212 at the 2026 ASCO® Annual Meeting https://ml-eu.globenewswire.com/media/9e6a027a-eb6c-4e34-993e-b8295e6d598d/small/orionpharma-rgb-press-releases-jpg.jpg https://healthylivingeurope.com/article/914016430-orion-pharma-julkistaa-ensimm-isi-kliinisi-tuloksia-faasi-1-2-teades-tutkimuksesta-odm-212-molekyylill-tead-est-j-2026-asco-vuosikokouksessa Healthy Living Europe en PressRelease 2026-05-21T07:30:00+00:00 Orion Pharma julkistaa ensimmäisiä kliinisiä tuloksia Faasi 1/2 TEADES-tutkimuksesta ODM-212-molekyylillä (TEAD-estäjä) 2026 ASCO®-vuosikokouksessa https://ml-eu.globenewswire.com/media/9e6a027a-eb6c-4e34-993e-b8295e6d598d/small/ https://healthylivingeurope.com/article/913991973-nanobiotix-announces-temporary-trading-halt-of-its-ordinary-shares-on-euronext-paris Healthy Living Europe en PressRelease 2026-05-21T06:30:00+00:00 Nanobiotix Announces Temporary Trading Halt of Its Ordinary Shares on Euronext Paris https://ml.globenewswire.com/media/36fb7b98-27d7-46cb-b989-fa31626657b8/small/nanobiotix-logo-jpg.jpg https://healthylivingeurope.com/article/913991978-nanobiotix-annonce-la-suspension-temporaire-du-cours-de-ses-actions-ordinaires-sur-euronext-paris Healthy Living Europe en PressRelease 2026-05-21T06:30:00+00:00 Nanobiotix annonce la suspension temporaire du cours de ses actions ordinaires sur Euronext Paris https://ml.globenewswire.com/media/36fb7b98-27d7-46cb-b989-fa31626657b8/small/nanobiotix-logo-jpg.jpg https://healthylivingeurope.com/article/913991911-infex-therapeutics-announces-positive-phase-iia-results-for-resp-x-in-non-cystic-fibrosis-bronchiectasis-patients-colonised-with-pseudomonas Healthy Living Europe en PressRelease 2026-05-21T06:00:00+00:00 Infex Therapeutics announces positive Phase IIa results for RESP-X in non-cystic fibrosis bronchiectasis patients colonised with Pseudomonas aeruginosa https://ml-eu.globenewswire.com/media/7e6719ab-feb1-4eb3-93c1-acca0cc4a3a1/small/infex-logo-png.png https://healthylivingeurope.com/article/913867842-the-brookbush-institute-publishes-a-new-article-rib-flare-assessment-the-myth-of-flared-ribs Healthy Living Europe en PressRelease 2026-05-20T17:24:42+00:00 The Brookbush Institute Publishes a NEW Article: 'Rib Flare Assessment: The Myth of 'Flared Ribs'' https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24862556-rib-flare-1200x800.jpeg https://healthylivingeurope.com/article/913647826-world-parkinson-coalition-announces-wpc-2026-award-recipients-honoring-global-impact-in-parkinsons-research-and-service Healthy Living Europe en PressRelease 2026-05-20T16:35:42+00:00 World Parkinson Coalition® Announces WPC 2026 Award Recipients Honoring Global Impact in Parkinsons Research and Service https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/21601133-7th-world-parkinson-congress-600x600.png https://healthylivingeurope.com/article/913850666-zanda-named-best-healthcare-technology-solution-of-the-year Healthy Living Europe en PressRelease 2026-05-20T15:34:06+00:00 Zanda Named Best Healthcare Technology Solution of the Year https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24415765-zanda-logo-3301x1276.png https://healthylivingeurope.com/article/913840574-ohhmed-medical-launches-uk-clinical-trial-evaluating-vertica-device-following-radical-prostatectomy Healthy Living Europe en PressRelease 2026-05-20T15:12:52+00:00 OhhMed Medical Launches UK Clinical Trial Evaluating Vertica Device Following Radical Prostatectomy https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24862355-vertica-plus-4096x2304.png https://healthylivingeurope.com/article/913841663-rna-editing-enzyme-reprograms-aggressive-bone-cancer-cells Healthy Living Europe en PressRelease 2026-05-20T15:09:55+00:00 RNA Editing Enzyme Reprograms Aggressive Bone Cancer Cells https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24862357-ijosb-50-3-1379x906.jpeg https://healthylivingeurope.com/article/913623978-synametrics-technologies-inc-announces-the-release-of-xeams-version-10-2-build-6432 Healthy Living Europe en PressRelease 2026-05-20T15:00:00+00:00 Synametrics Technologies Inc. announces the release of Xeams version 10.2 (Build 6432) https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/19504662-xeams-4000x2333.jpeg https://healthylivingeurope.com/article/913815243-sciensus-and-rare-patient-voice-spotlight-rare-disease-access-burden-in-europe-with-ispor-2026-poster Healthy Living Europe en PressRelease 2026-05-20T15:00:00+00:00 Sciensus and Rare Patient Voice spotlight rare disease access burden in Europe with ISPOR 2026 poster https://healthylivingeurope.com/article/913965589-sifts-microplastic-binding-supplement-claims-evaluated-the-chitosan-fiber-formula-for-daily-microplastic-particle-exposure-support Healthy Living Europe en PressRelease 2026-05-21T02:03:16+00:00 Sifts Microplastic Binding Supplement Claims Evaluated: The Chitosan Fiber Formula for Daily Microplastic Particle Exposure Support https://zingfast.com/wp-content/uploads/2026/05/Sifts-Microplastic-Binding-Supplement.jpg https://healthylivingeurope.com/article/913811602-telehealth-software-market-competitive-positioning-across-global-players Healthy Living Europe en PressRelease 2026-05-20T13:25:22+00:00 Telehealth Software Market Competitive Positioning Across Global Players https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24862142-telehealth-software-market-segm-1920x1080.png https://healthylivingeurope.com/article/913808721-structural-health-monitoring-market-competitive-environment-and-key-company-insights Healthy Living Europe en PressRelease 2026-05-20T13:25:21+00:00 Structural Health Monitoring Market Competitive Environment and Key Company Insights https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24862119-structural-health-monitoring-ma-1920x1080.png https://healthylivingeurope.com/article/913965583-neurozen-under-investigation-critical-assessment-reveals-shocking-consumer-report-details-disclosed Healthy Living Europe en PressRelease 2026-05-21T01:09:36+00:00 NeuroZen Under Investigation - Critical Assessment Reveals Shocking Consumer Report Details Disclosed https://zingfast.com/wp-content/uploads/2026/05/NeuroZen.jpg https://healthylivingeurope.com/article/913803185-small-cell-backhaul-market-competition-patterns-and-positioning-strategies Healthy Living Europe en PressRelease 2026-05-20T12:59:56+00:00 Small Cell Backhaul Market Competition Patterns and Positioning Strategies https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24862086-small-cell-backhaul-market-segm-1920x1080.png https://healthylivingeurope.com/article/913803013-how-competition-is-evolving-in-the-healthcare-consulting-services-market Healthy Living Europe en PressRelease 2026-05-20T12:59:54+00:00 How Competition Is Evolving in the Healthcare Consulting Services Market https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24862078-healthcare-consulting-services-1920x1080.png https://healthylivingeurope.com/article/913786872-real-world-evidence-solutions-market-competitive-analysis-trends-leaders-and-strategic-moves Healthy Living Europe en PressRelease 2026-05-20T12:59:48+00:00 Real World Evidence Solutions Market Competitive Analysis: Trends, Leaders, and Strategic Moves https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24861969-real-world-evidence-solutions-m-1920x1080.png https://healthylivingeurope.com/article/913778534-narcolepsy-market-2026-competitive-trends-shaping-industry-leadership Healthy Living Europe en PressRelease 2026-05-20T12:59:43+00:00 Narcolepsy Market 2026: Competitive Trends Shaping Industry Leadership https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24861910-narcolepsy-market-competitor-an-1920x1080.png https://healthylivingeurope.com/article/913586810-fascia-clinics-calls-for-broader-approach-to-pelvic-floor-dysfunction-following-new-swedish-national-guidelines Healthy Living Europe en PressRelease 2026-05-20T12:30:00+00:00 Fascia Clinics Calls for Broader Approach to Pelvic Floor Dysfunction Following New Swedish National Guidelines https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24860676-fascia-clinics-logo-917x348.png https://healthylivingeurope.com/article/913938070-relay-therapeutics-announces-pricing-of-public-offering-of-common-stock Healthy Living Europe en PressRelease 2026-05-21T00:21:22+00:00 Relay Therapeutics Announces Pricing of Public Offering of Common Stock https://ml.globenewswire.com/media/079b6db5-ce81-4a81-9cde-d97f86c569ae/small/logo-banner-small-png.png https://healthylivingeurope.com/article/912827806-omega-bio-tek-launches-mag-bind-blood-saliva-dna-lsp-kit-to-streamline-high-throughput-dna-extraction Healthy Living Europe en PressRelease 2026-05-20T12:15:00+00:00 Omega Bio-tek Launches Mag-Bind® Blood & Saliva DNA LSP Kit to Streamline High-Throughput DNA Extraction https://healthylivingeurope.com/article/912825723-omega-bio-tek-launches-mag-bind-total-rna-xpress-kit-for-rapid-high-quality-rna-purification Healthy Living Europe en PressRelease 2026-05-20T11:45:00+00:00 Omega Bio-tek Launches Mag-Bind® Total RNA Xpress Kit for Rapid, High-Quality RNA Purification https://healthylivingeurope.com/article/913739383-100-women-s-health-advocates-press-congress-to-end-funding-reimbursement-regulatory-gaps Healthy Living Europe en PressRelease 2026-05-20T11:30:00+00:00 100+ Women's Health Advocates Press Congress to End Funding, Reimbursement & Regulatory Gaps https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24861724-wha-logo-1920x1003.jpeg https://healthylivingeurope.com/article/913626996-valkit-ai-appoints-saas-and-investment-technology-leader-brian-nejmeh-to-advisory-board Healthy Living Europe en PressRelease 2026-05-20T11:00:00+00:00 valkit.ai Appoints SaaS and Investment Technology Leader Brian Nejmeh to Advisory Board https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24860981-brian-nejmeh-800x800.jpeg https://healthylivingeurope.com/article/913809118-bonyf-nv-annual-general-meeting-date-and-business-update Healthy Living Europe en PressRelease 2026-05-20T10:58:53+00:00 bonyf NV – Annual General Meeting Date and Business Update https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24862120-agm-2117x743.png https://healthylivingeurope.com/article/913481453-targeted-therapy-improves-mobility-in-children-with-rare-bone-disorder Healthy Living Europe en PressRelease 2026-05-20T10:30:00+00:00 Targeted Therapy Improves Mobility in Children with Rare Bone Disorder https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24859955-ijosb-55-4-1379x906.jpeg https://healthylivingeurope.com/article/913731526-zaniez-embraces-natural-successful-neurological-equine-and-aquatic-therapies-at-farm-trade-school-for-spectrum-students Healthy Living Europe en PressRelease 2026-05-20T10:30:00+00:00 Zaniez Embraces Natural, Successful Neurological Equine and Aquatic Therapies at Farm Trade School for Spectrum Students https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24848265-zaniez-1181x1181.png https://healthylivingeurope.com/article/913650388-analysis-report-on-market-size-share-and-trends-of-recurrent-implantation-failure-panels-by-product Healthy Living Europe en PressRelease 2026-05-20T09:53:47+00:00 Analysis Report on Market Size, Share, and Trends of Recurrent Implantation Failure Panels by Product https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://healthylivingeurope.com/article/913647317-industry-report-on-protein-structure-prediction-platforms-market-competition-and-future-opportunities Healthy Living Europe en PressRelease 2026-05-20T09:53:09+00:00 Industry Report on Protein Structure Prediction Platforms: Market Competition and Future Opportunities https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://healthylivingeurope.com/article/913638603-market-analysis-report-on-point-of-care-poc-tuberculosis-tb-ultra-sensitive-nucleic-acid-amplification-test-naat Healthy Living Europe en PressRelease 2026-05-20T09:51:42+00:00 Market Analysis Report on Point of Care (POC) Tuberculosis (TB) Ultra-Sensitive Nucleic Acid Amplification Test (NAAT) https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://healthylivingeurope.com/article/913910039-dyne-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Healthy Living Europe en PressRelease 2026-05-20T21:30:00+00:00 Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/2aa597a4-9b5c-4f0c-9ada-c5e06fa7d4de/small/dynelogo-r-final-full-color-rgb-jpg.jpg https://healthylivingeurope.com/article/913797653-kfsh-highlights-the-rise-of-emerging-ai-health-leaders-at-world-economic-forum-annual-health-roundtable-2026 Healthy Living Europe en PressRelease 2026-05-20T09:24:32+00:00 KFSH Highlights the Rise of Emerging AI-Health Leaders at World Economic Forum Annual Health Roundtable 2026 https://healthylivingeurope.com/article/913791113-which-crdmo-is-good-for-global-drug-manufacturing Healthy Living Europe en PressRelease 2026-05-20T08:51:28+00:00 Which CRDMO is good for Global Drug Manufacturing? https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24861993-wuxi-apptec-s-global-network-1456x811.png https://healthylivingeurope.com/article/913769126-chinese-top-3-microscope-manufacturer-in-2026-leading-innovation-and-advancing-global-optical-technology Healthy Living Europe en PressRelease 2026-05-20T08:43:11+00:00 Chinese Top 3 Microscope Manufacturer in 2026: Leading Innovation and Advancing Global Optical Technology https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24861814-logo-for-chongqing-scope-instru-800x800.png https://healthylivingeurope.com/article/913910072-johns-hopkins-health-plans-awards-60-000-to-maryland-and-virginia-organizations Healthy Living Europe en PressRelease 2026-05-20T20:42:03+00:00 Johns Hopkins Health Plans Awards $60,000 to Maryland and Virginia Organizations https://ml.globenewswire.com/media/404affac-e9f4-456a-93bd-0ee405e6de49/small/johns-hopkins-logo-jpg.jpg https://healthylivingeurope.com/article/913787994-cryotem-breaks-ground-as-new-method-added-to-u-s-pharmacopeia-s-updated-aav-reference-standard-certificates Healthy Living Europe en PressRelease 2026-05-20T08:33:21+00:00 CryoTEM breaks ground as new method added to U.S. Pharmacopeia's updated AAV reference standard certificates https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24861972-usp-2699x2412.jpeg https://healthylivingeurope.com/article/913910059-strongest-phentermine-alternatives-2026-what-otc-options-are-commonly-compared-to-phentermine-phenq-formulation-assessment-using-the-scale-9 Healthy Living Europe en PressRelease 2026-05-20T20:31:51+00:00 Strongest Phentermine Alternatives 2026: What OTC Options Are Commonly Compared to Phentermine? PhenQ Formulation Assessment Using the SCALE-9 Evaluation Model https://ml.globenewswire.com/media/e5837328-83d5-4070-b167-275f236652e0/medium/phenq.png https://healthylivingeurope.com/article/913909512-information-on-the-total-number-of-voting-rights-and-shares Healthy Living Europe en PressRelease 2026-05-20T20:30:00+00:00 Information on the total number of voting rights and shares https://ml-eu.globenewswire.com/media/a71f8653-a2aa-46a0-ad48-7eb6b9091673/small/logo-nyxoah-rgb-png.png https://healthylivingeurope.com/article/913909526-informations-sur-le-nombre-total-de-droits-de-vote-et-d-actions Healthy Living Europe en PressRelease 2026-05-20T20:30:00+00:00 Informations sur le nombre total de droits de vote et d'actions https://ml-eu.globenewswire.com/media/a71f8653-a2aa-46a0-ad48-7eb6b9091673/small/ https://healthylivingeurope.com/article/913909554-l-assembl-e-g-n-rale-mixte-de-cellectis-se-tiendra-le-le-25-juin-2026 Healthy Living Europe en PressRelease 2026-05-20T20:30:00+00:00 L’Assemblée Générale Mixte de Cellectis se tiendra le le 25 juin 2026 https://ml.globenewswire.com/media/a84ce25b-a774-4635-9b79-d45241f5decc/small/cellectis-logo-png.png https://healthylivingeurope.com/article/913909559-cellectis-annual-shareholders-general-meeting-to-be-held-on-june-25-2026 Healthy Living Europe en PressRelease 2026-05-20T20:30:00+00:00 Cellectis’ Annual Shareholders General Meeting to be Held on June 25, 2026 https://ml.globenewswire.com/media/a84ce25b-a774-4635-9b79-d45241f5decc/small/cellectis-logo-png.png https://healthylivingeurope.com/article/913909611-cvrx-to-present-at-the-william-blair-46th-annual-growth-stock-conference Healthy Living Europe en PressRelease 2026-05-20T20:30:00+00:00 CVRx to Present at the William Blair 46th Annual Growth Stock Conference https://ml.globenewswire.com/media/04c4feba-7841-4ac8-8ca5-6c03be383a0e/small/cvrx-outsmart-the-heart-logo-rgb-blue-png.png https://healthylivingeurope.com/article/913909902-palvella-therapeutics-presents-new-selva-and-toiva-data-at-the-2026-international-society-for-the-study-of-vascular-anomalies-world-congress Healthy Living Europe en PressRelease 2026-05-20T20:30:00+00:00 Palvella Therapeutics Presents New SELVA and TOIVA Data at the 2026 International Society for the Study of Vascular Anomalies World Congress Supporting QTORIN™ Rapamycin as a Potential First-in-Disease Therapy for Multiple Serious, Rare Vascular… https://ml.globenewswire.com/media/83fd569b-5e6c-46ad-882a-6430f8ab755a/small/palvella-2025-logo-new-jpg.jpg https://healthylivingeurope.com/article/913910043-lemaitre-to-participate-at-upcoming-investor-conferences-in-june Healthy Living Europe en PressRelease 2026-05-20T20:25:14+00:00 LeMaitre to Participate at Upcoming Investor Conferences in June https://ml.globenewswire.com/media/8b8755b7-6f04-4650-9c94-0a2d0654fd49/small/lemaitre-2color-rgb-jpg.jpg https://healthylivingeurope.com/article/913910006-bioadaptives-launches-myndsystem-website-the-first-supplement-platform-designed-to-support-both-daytime-cognitive-performance-and-overnight-brain Healthy Living Europe en PressRelease 2026-05-20T20:15:53+00:00 BioAdaptives Launches MyndSystem™ Website — The First Supplement Platform Designed to Support Both Daytime Cognitive Performance and Overnight Brain Recovery https://ml.globenewswire.com/media/ad289631-6a2e-4b27-bc43-6b7ac688a537/small/bioadaptives-logo-jpg.jpg https://healthylivingeurope.com/article/913909569-dentsply-sirona-to-participate-in-the-2026-stifel-jaws-paws-conference Healthy Living Europe en PressRelease 2026-05-20T20:15:00+00:00 Dentsply Sirona to Participate in the 2026 Stifel Jaws & Paws Conference https://ml.globenewswire.com/media/91e36dfa-44e3-4905-a186-3a988bd67ab8/small/dentsply-sirona-grey-80-black-rgb-jpg.JPG https://healthylivingeurope.com/article/913573665-dentavit-pioneers-biological-dentistry-and-holistic-orthodontics-in-switzerland Healthy Living Europe en PressRelease 2026-05-20T08:10:34+00:00 Dentavit Pioneers Biological Dentistry and Holistic Orthodontics in Switzerland https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24860512-dentavit-symbol-1200x800.jpeg https://healthylivingeurope.com/article/913909891-vivos-therapeutics-reports-first-quarter-2026-financial-results-and-provides-operational-update Healthy Living Europe en PressRelease 2026-05-20T20:10:00+00:00 Vivos Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational Update https://ml.globenewswire.com/media/22d07f60-2e17-421d-bbc3-748c2402061e/small/picture2-jpg.JPG https://healthylivingeurope.com/article/913909551-ceribell-to-participate-in-the-william-blair-46th-annual-growth-stock-conference Healthy Living Europe en PressRelease 2026-05-20T20:05:00+00:00 Ceribell to Participate in the William Blair 46th Annual Growth Stock Conference https://ml.globenewswire.com/media/937c5c00-41f8-45ff-b294-5f9c3f6ab2cf/small/cbll-square-logo-500x500-png.png https://healthylivingeurope.com/article/913909630-equillium-to-host-virtual-investor-event-to-share-new-insights-into-the-aryl-hydrocarbon-receptor-ahr-and-mir-124-axis Healthy Living Europe en PressRelease 2026-05-20T20:05:00+00:00 Equillium to Host Virtual Investor Event to Share New Insights into the Aryl Hydrocarbon Receptor (AhR) and miR-124 Axis https://ml.globenewswire.com/media/14ce766d-e697-461f-a27c-c1ee49c0eeff/small/equillium-logo-360x180-jpg.jpg https://healthylivingeurope.com/article/913909669-rapport-therapeutics-to-participate-in-the-jefferies-global-healthcare-conference-and-goldman-sachs-47th-annual-global-healthcare-conference Healthy Living Europe en PressRelease 2026-05-20T20:05:00+00:00 Rapport Therapeutics to Participate in the Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conference https://ml.globenewswire.com/media/7777ee9b-f88b-4a59-a668-d81520f9d32c/small/rapport-logo-color-rgb-png.png https://healthylivingeurope.com/article/913909676-longeveron-issues-letter-to-stockholders-highlighting-corporate-strategy-strategic-partnering-approach-and-2026-key-priorities Healthy Living Europe en PressRelease 2026-05-20T20:05:00+00:00 Longeveron Issues Letter to Stockholders Highlighting Corporate Strategy, Strategic Partnering Approach and 2026 Key Priorities https://ml.globenewswire.com/media/cde71c09-a5f1-424d-837b-80f8786d82a5/medium/stephen-willard.jpg https://healthylivingeurope.com/article/913909854-20-20-biolabs-reports-first-quarter-2026-financial-results-and-recent-operational-progress Healthy Living Europe en PressRelease 2026-05-20T20:05:00+00:00 20/20 BioLabs Reports First Quarter 2026 Financial Results and Recent Operational Progress https://ml.globenewswire.com/media/bcaf95ca-9983-408c-bc61-646e4ee2f925/small/2020-biolabs-logo-png.png https://healthylivingeurope.com/article/913909893-eledon-pharmaceuticals-to-present-new-long-term-data-from-phase-2-bestow-trial-of-tegoprubart-for-the-prevention-of-rejection-in-kidney Healthy Living Europe en PressRelease 2026-05-20T20:05:00+00:00 Eledon Pharmaceuticals to Present New Long-Term Data from Phase 2 BESTOW Trial of Tegoprubart for the Prevention of Rejection in Kidney Transplantation at American Transplant Congress https://ml.globenewswire.com/media/5e2f90ec-c9a5-4fcd-99c8-2c8c838ac033/small/eledon-logo-1230-png.png https://healthylivingeurope.com/article/913909828-corvus-pharmaceuticals-to-present-at-the-2026-jefferies-global-healthcare-conference-and-goldman-sachs-47th-annual-global-healthcare-conference Healthy Living Europe en PressRelease 2026-05-20T20:01:00+00:00 Corvus Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conference https://ml.globenewswire.com/media/d05c16d1-5c24-4242-84b5-aea3951ca251/small/corvus-logo-large-jpg.jpg https://healthylivingeurope.com/article/913909540-cytokinetics-to-hold-annual-meeting-of-stockholders Healthy Living Europe en PressRelease 2026-05-20T20:00:00+00:00 Cytokinetics to Hold Annual Meeting of Stockholders https://ml.globenewswire.com/media/52e2be9f-e9e3-43af-a747-123fdcac4253/small/cytokinetics-png.png https://healthylivingeurope.com/article/913782459-spinal-cord-stimulation-system-market-to-reach-us-5-8-billion-by-2033-at-7-9-cagr Healthy Living Europe en PressRelease 2026-05-20T07:58:59+00:00 Spinal Cord Stimulation System Market to Reach US$5.8 Billion by 2033 at 7.9% CAGR https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24861937-spinal-cord-stimulation-system-1040x720.png https://healthylivingeurope.com/article/913909871-clinical-trials-day-gains-national-recognition-through-first-ever-u-s-proclamation-initiative Healthy Living Europe en PressRelease 2026-05-20T19:29:46+00:00 Clinical Trials Day Gains National Recognition Through First-Ever U.S. Proclamation Initiative https://ml.globenewswire.com/media/NDkyZDdmMzQtZjIzMi00OTUwLTlkMjYtYzkzNTc1ZWNkMmE5LTUwMDE1NDYzNi0yMDI2LTA1LTIwLWVu/tiny/Association-of-Clinical-Resear.png https://healthylivingeurope.com/article/913778127-small-volume-injectable-svi-market-to-reach-us-29-9-billion-by-2033-at-5-4-cagr Healthy Living Europe en PressRelease 2026-05-20T07:19:38+00:00 Small Volume Injectable (SVI) Market to Reach US$ 29.9 Billion by 2033 at 5.4% CAGR https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24861907-small-volume-injectable-svi-1040x720.png https://healthylivingeurope.com/article/913776034-robotic-assisted-hip-replacement-market-to-reach-us-10-9-billion-by-2033-at-4-9-cagr-persistence-market-research Healthy Living Europe en PressRelease 2026-05-20T07:19:25+00:00 Robotic-Assisted Hip Replacement Market to Reach US$ 10.9 Billion by 2033 at 4.9% CAGR | Persistence Market Research https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24861895-robotic-assisted-hip-replacemen-1040x720.png https://healthylivingeurope.com/article/913780054-generalized-anxiety-disorder-gad-treatment-market-to-reach-us-5-3-billion-by-2033-at-6-5-cagr Healthy Living Europe en PressRelease 2026-05-20T07:13:10+00:00 Generalized Anxiety Disorder (GAD) Treatment Market to Reach US$ 5.3 Billion by 2033 at 6.5% CAGR https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24861917-generalized-anxiety-disorder-g-1040x720.jpeg https://healthylivingeurope.com/article/913779110-restriction-enzymes-market-to-reach-us-411-4-million-by-2033-at-7-3-cagr Healthy Living Europe en PressRelease 2026-05-20T07:03:29+00:00 Restriction Enzymes Market to Reach US$411.4 Million by 2033 at 7.3% CAGR https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24861915-restriction-enzymes-1040x720.png https://healthylivingeurope.com/article/913883552-aim-immunotech-announces-2-4-million-financing-including-concurrent-registered-direct-offering-and-private-placement Healthy Living Europe en PressRelease 2026-05-20T19:02:14+00:00 AIM ImmunoTech Announces $2.4 Million Financing, Including Concurrent Registered Direct Offering and Private Placement https://ml.globenewswire.com/media/8e85b83b-047f-4f99-9c51-1aa232ffe9bb/small/aimlogo-jpg.jpg https://healthylivingeurope.com/article/913374285-why-are-global-buyers-choosing-kebon-first-aid-kit-solutions-for-emergency-preparedness-purchasing Healthy Living Europe en PressRelease 2026-05-20T06:53:17+00:00 Why Are Global Buyers Choosing Kebon First Aid Kit Solutions for Emergency Preparedness Purchasing https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24859172-first-aid-kit-1293x708.png https://healthylivingeurope.com/article/913775234-genomic-cancer-testing-market-to-reach-us-75-9-billion-by-2033-at-16-8-cagr-persistence-market-research Healthy Living Europe en PressRelease 2026-05-20T06:38:10+00:00 Genomic Cancer Testing Market to Reach US$ 75.9 Billion by 2033 at 16.8% CAGR | Persistence Market Research https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24861883-cell-therapy-monitoring-kits-1040x720.png https://healthylivingeurope.com/article/913883546-jupiter-neurosciences-announces-pricing-of-2-0-million-registered-direct-offering Healthy Living Europe en PressRelease 2026-05-20T18:38:00+00:00 Jupiter Neurosciences Announces Pricing of $2.0 Million Registered Direct Offering https://ml.globenewswire.com/media/4e829d7e-ecf6-46ad-98fe-479755d626e1/small/image-png.png https://healthylivingeurope.com/article/913551899-protocol-validity-protection-added-in-penta-security-s-cloudbric-managed-rules Healthy Living Europe en PressRelease 2026-05-20T06:30:00+00:00 Protocol Validity Protection Added in Penta Security’s Cloudbric Managed Rules https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24860244-cmr-protocol-validity-2156x993.png https://healthylivingeurope.com/article/913883542-iafns-and-academy-of-nutrition-and-dietetics-publish-guidance-to-help-practitioners-navigate-questions-around-highly-processed-foods Healthy Living Europe en PressRelease 2026-05-20T18:08:52+00:00 IAFNS and Academy of Nutrition and Dietetics Publish Guidance to Help Practitioners Navigate Questions Around Highly Processed Foods https://ml.globenewswire.com/media/N2NjZWY5OGUtNTM4Mi00MzBiLTk5OTItNDM2YTE5MTVjZDZhLTEyNzAxODMtMjAyNi0wNS0yMC1lbg==/tiny/Academy-of-Nutrition-and-Diete.png https://healthylivingeurope.com/article/913009279-abl-diagnostics-renforce-son-leadership-mondial-dans-le-g-notypage-vih-avec-deepchek-whole-genome-hiv Healthy Living Europe en PressRelease 2026-05-20T06:00:00+00:00 ABL Diagnostics renforce son leadership mondial dans le génotypage VIH avec DeepChek® Whole Genome HIV https://healthylivingeurope.com/article/913010661-abl-diagnostics-unveils-next-generation-hiv-genotyping-innovation-with-the-industry-s-broadest-portfolio Healthy Living Europe en PressRelease 2026-05-20T06:00:00+00:00 ABL Diagnostics Unveils Next-Generation HIV Genotyping Innovation with the Industry’s Broadest Portfolio https://healthylivingeurope.com/article/913883514-fda-warns-retailers-selling-illegal-tobacco-products-that-look-like-everyday-products Healthy Living Europe en PressRelease 2026-05-20T17:29:33+00:00 FDA Warns Retailers Selling Illegal Tobacco Products That Look Like Everyday Products https://ml.globenewswire.com/media/MTdmNzZjMDEtMWVmOS00ZmZiLThlNGQtODY1ODdlZTBlY2JhLTUwMDE1NDE1NC0yMDI2LTA1LTIwLWVu/tiny/FDA.png https://healthylivingeurope.com/article/913354965-author-connie-leininger-releases-tara-s-soul-a-powerful-sequel-to-wounded-souls-exploring-healing-and-redemption Healthy Living Europe en PressRelease 2026-05-20T05:25:57+00:00 Author Connie Leininger Releases Tara’s Soul, a Powerful Sequel to Wounded Souls, Exploring Healing and Redemption https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24859073-tara-s-soul-book-cover-1600x2560.jpeg https://healthylivingeurope.com/article/913718248-woah-launches-prevent-forum-a-public-private-dialogue-mechanism-to-unlock-full-potential-of-animal-disease-prevention Healthy Living Europe en PressRelease 2026-05-20T05:08:13+00:00 WOAH launches PREVENT Forum, a public-private dialogue mechanism to unlock full potential of animal disease prevention https://healthylivingeurope.com/article/913734037-2026-china-top-3-gynecological-operating-table-manufacturer-the-enterprise-takes-the-lead-to-drive-industry-development Healthy Living Europe en PressRelease 2026-05-20T04:28:08+00:00 2026 China Top 3 Gynecological Operating Table Manufacturer：The Enterprise Takes the Lead to Drive Industry Development https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24861697-shandong-yuda-medical-device-te-800x800.png https://healthylivingeurope.com/article/913859717-leafwell-advances-medical-cannabis-as-clinically-validated-solution-for-cancer-related-symptoms-and-chronic-pain-supports-employer-sponsored-mental Healthy Living Europe en PressRelease 2026-05-20T15:17:15+00:00 Leafwell Advances Medical Cannabis as Clinically Validated Solution for Cancer-Related Symptoms and Chronic Pain, Supports Employer-Sponsored Mental Health Benefits https://ml.globenewswire.com/media/86423433-b118-4b2b-8f83-a8cc0d68098c/small/leafwell-logo-green-and-black-2021-png.png https://healthylivingeurope.com/article/913859700-mink-therapeutics-reports-new-data-on-agent-797-an-allo-inkt-cell-therapy-at-ats-2026-simultaneously-published-in-clinical-immunology-communications Healthy Living Europe en PressRelease 2026-05-20T15:07:14+00:00 MiNK Therapeutics Reports New Data on agenT-797, an allo-iNKT Cell Therapy at ATS 2026; Simultaneously Published in Clinical Immunology Communications https://ml.globenewswire.com/media/6aa8e960-515a-40d6-9894-39ca47f5c84e/small/mink-logo-loyal-blue-and-light-blue-png.png https://healthylivingeurope.com/article/913859093-ama-unveils-infographic-to-help-patients-safely-navigate-ai-in-healthcare Healthy Living Europe en PressRelease 2026-05-20T14:30:00+00:00 AMA Unveils Infographic to Help Patients Safely Navigate AI in Healthcare https://ml.globenewswire.com/media/YWI5ZWE1ZGItMGJhMC00ZmU3LWIwZjctYTdlNzVmNTIxMjJkLTEwOTg0MDUtMjAyNi0wNS0yMC1lbg==/tiny/American-Medical-Association.png https://healthylivingeurope.com/article/913858606-how-to-boost-testosterone-after-40-safe-testosterone-boosters-for-men-over-40-and-50-for-muscle-growth-energy-stamina-and-performance-in-2026 Healthy Living Europe en PressRelease 2026-05-20T14:19:09+00:00 How To Boost Testosterone After 40?| Safe Testosterone Boosters for Men Over 40 and 50 For Muscle Growth, Energy, Stamina and Performance in 2026 – Launched By Testoprime https://ml-eu.globenewswire.com/Resource/Download/329f05ae-17dd-42ae-88e0-9b7ff687ebcf/image2.png https://healthylivingeurope.com/article/913858813-ronald-mcdonald-house-new-england-launches-brand-revitalization-deepening-its-mission-to-keep-families-close Healthy Living Europe en PressRelease 2026-05-20T14:00:00+00:00 Ronald McDonald House New England Launches Brand Revitalization, Deepening its Mission to Keep Families Close https://pressranger.s3.us-west-1.amazonaws.com/3291515/rmh_newengland_logo_hrz_color_rgb_pos.png https://healthylivingeurope.com/article/913859084-regional-health-properties-reports-first-quarter-2026-results Healthy Living Europe en PressRelease 2026-05-20T13:41:00+00:00 Regional Health Properties Reports First Quarter 2026 Results https://ml.globenewswire.com/media/bfd51062-4a60-4cf0-9f2f-a4b109b52e4a/small/logo-jpg.jpg https://healthylivingeurope.com/article/913835677-tru-1-by-bluegenes-launches-to-advance-precision-health-through-smarter-genetic-insights Healthy Living Europe en PressRelease 2026-05-20T13:15:00+00:00 Tru-1 By BlueGenes Launches to Advance Precision Health Through Smarter Genetic Insights https://ml.globenewswire.com/media/ZWViMTQwZTctODE3YS00NGIwLTk0NzgtYjIyYzQzNzYwOWM3LTUwMDEzNTI2MC0yMDI2LTA1LTIwLWVu/tiny/BlueGenesLab.png https://healthylivingeurope.com/article/913834406-new-studies-show-adherence-to-monthly-injectable-buprenorphine-is-associated-with-relapse-reduction-and-lower-healthcare-utilization Healthy Living Europe en PressRelease 2026-05-20T13:00:00+00:00 New Studies Show Adherence to Monthly Injectable Buprenorphine is Associated with Relapse Reduction and Lower Healthcare Utilization https://ml-eu.globenewswire.com/media/42de3285-90ea-4020-a3ad-25f71026b41a/small/indivior-logo-jpg.jpg https://healthylivingeurope.com/article/913835033-alzheimer-s-research-sites-honor-national-clinical-trials-day Healthy Living Europe en PressRelease 2026-05-20T13:00:00+00:00  Alzheimer’s Research Sites Honor National Clinical Trials Day https://ml.globenewswire.com/media/79913531-32c1-476a-8d22-887b6775a191/small/gap-logo-1708444397196-png.png https://healthylivingeurope.com/article/913835062-biostem-technologies-announces-notice-of-allowance-for-four-u-s-design-patent-applications-covering-fenestrated-human-placental-allografts-and-one Healthy Living Europe en PressRelease 2026-05-20T13:00:00+00:00 BioStem Technologies Announces Notice of Allowance for Four U.S. Design Patent Applications Covering Fenestrated Human Placental Allografts and One European Patent https://ml.globenewswire.com/media/f4323fdf-217c-4eaf-94ad-897e8158965b/small/biostem-technologies-logo.png https://healthylivingeurope.com/article/913835675-aeroflow-urology-donates-to-national-diaper-bank-network-and-united-way-to-improve-national-health-equity Healthy Living Europe en PressRelease 2026-05-20T13:00:00+00:00 Aeroflow Urology Donates to National Diaper Bank Network and United Way to Improve National Health Equity https://ml.globenewswire.com/media/f0030ee9-d8c8-4321-a610-4bb1ed358418/small/aeroflow-health-png.png https://healthylivingeurope.com/article/913835697-jenavalve-appoints-tonya-porter-as-vice-president-of-regulatory-affairs Healthy Living Europe en PressRelease 2026-05-20T13:00:00+00:00 JenaValve Appoints Tonya Porter as Vice President of Regulatory Affairs https://ml.globenewswire.com/media/a1ab2446-a463-4b8f-bc18-26a5ca117176/small/jv-logo-h-rgb-l-1607-png.png https://healthylivingeurope.com/article/913836064-codexis-highlights-stereochemistry-advances-for-scalable-rna-manufacturing-at-tides-usa Healthy Living Europe en PressRelease 2026-05-20T13:00:00+00:00 Codexis highlights stereochemistry advances for scalable RNA manufacturing at TIDES USA https://ml.globenewswire.com/media/ebbfa755-c2db-4783-aace-43c700ba3369/small/codexis-logo-september-2023-png.png https://healthylivingeurope.com/article/913835684-ernexa-therapeutics-releases-virtual-investor-kol-connect-segment-featuring-dr-elena-ratner-highlighting-ovarian-cancer-landscape-and-erna-101 Healthy Living Europe en PressRelease 2026-05-20T12:31:00+00:00 Ernexa Therapeutics Releases Virtual Investor KOL Connect Segment Featuring Dr. Elena Ratner Highlighting Ovarian Cancer Landscape and ERNA-101 Opportunity https://ml.globenewswire.com/media/bb12f9ec-b7e7-4d8c-92df-cf27e238c398/small/ernexa-color-png.png https://healthylivingeurope.com/article/913834668-polypid-to-participate-in-the-craig-hallum-23rd-annual-institutional-investor-conference Healthy Living Europe en PressRelease 2026-05-20T12:30:00+00:00 PolyPid to Participate in the Craig-Hallum 23rd Annual Institutional Investor Conference https://ml.globenewswire.com/media/202fc254-aac1-49c2-a08d-cc0efc938460/small/polypid-logo-final-rgb-2x-100-jpg.jpg https://healthylivingeurope.com/article/913835049-iradimed-corporation-to-present-at-the-goldman-sachs-47th-annual-global-healthcare-conference Healthy Living Europe en PressRelease 2026-05-20T12:30:00+00:00 IRADIMED CORPORATION to Present at the Goldman Sachs 47th Annual Global Healthcare Conference https://ml.globenewswire.com/media/f353c867-559d-43a8-935c-ab497045e743/small/logo-gif.gif https://healthylivingeurope.com/article/913835158-stablecoin-development-corporation-reports-first-quarter-2026-financial-results Healthy Living Europe en PressRelease 2026-05-20T12:30:00+00:00 Stablecoin Development Corporation Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/YTcyMTk0YjUtM2U4Yi00NDBiLWFjNjUtZTMyZTFjMjU1MTIwLTEwMjg2MTQtMjAyNi0wNS0yMC1lbg==/tiny/Stablecoin-Development-Corpora.png https://healthylivingeurope.com/article/913834741-sustainability-leader-ashley-mckeon-selected-as-soil-health-institute-s-president-and-ceo Healthy Living Europe en PressRelease 2026-05-20T12:15:00+00:00 Sustainability Leader Ashley McKeon Selected as Soil Health Institute’s President and CEO https://ml.globenewswire.com/media/02787cce-432b-4491-86ff-aa145be87ff4/medium/ashley-mckeon.png https://healthylivingeurope.com/article/913836632-pharmala-biotech-signs-term-sheet-to-license-exclusive-u-s-rights-to-ala-002-its-next-generation-mdma-therapeutic-to-jupiter-neurosciences-inc Healthy Living Europe en PressRelease 2026-05-20T12:15:00+00:00 PharmAla Biotech Signs Term Sheet to License Exclusive U.S. Rights to ALA-002, Its Next-Generation MDMA Therapeutic, to Jupiter Neurosciences, Inc. (NASDAQ: JUNS) in a Transaction Valued at Over $100 Million https://ml.globenewswire.com/media/20158980-8674-43e3-a0be-a10dca42410d/small/pharmala-biotech-logo-800-x-422-png.png https://healthylivingeurope.com/article/913834733-protara-therapeutics-to-present-at-the-td-cowen-7th-annual-oncology-innovation-summit-insights-for-asco-eha Healthy Living Europe en PressRelease 2026-05-20T12:00:00+00:00 Protara Therapeutics to Present at the TD Cowen 7th Annual Oncology Innovation Summit: Insights for ASCO & EHA https://ml.globenewswire.com/media/ba98d7ed-6917-452d-a864-6f60caa53c1b/small/protara-therapeutics-2x-png.png https://healthylivingeurope.com/article/913835079-madrigal-to-present-new-data-from-the-company-s-mash-program-at-easl-2026-demonstrating-the-effects-of-rezdiffra-on-markers-of-cardiovascular-and Healthy Living Europe en PressRelease 2026-05-20T12:00:00+00:00 Madrigal to Present New Data from the Company’s MASH Program at EASL 2026 Demonstrating the Effects of Rezdiffra on Markers of Cardiovascular and Portal Hypertension Risk https://ml.globenewswire.com/media/8fec8de1-1a2e-4f6c-a679-fc43002276ba/small/madrigal-logo-jpg.jpg https://healthylivingeurope.com/article/913835199-23andme-partners-with-healthex-to-connect-medical-records-with-your-dna-for-the-future-of-personalized-medicine Healthy Living Europe en PressRelease 2026-05-20T12:00:00+00:00 23andMe Partners with HealthEx to Connect Medical Records with Your DNA for the Future of Personalized Medicine https://ml.globenewswire.com/media/82f9b45c-015c-4db1-8f92-9d6ea1bae6be/medium/healthex-partnership-connects-medical-records-with-23andme.jpg https://healthylivingeurope.com/article/913835206-humacyte-announces-symvess-is-now-under-contract-with-the-strategic-acquisition-center-sac-of-the-u-s-department-of-veterans-affairs Healthy Living Europe en PressRelease 2026-05-20T12:00:00+00:00 Humacyte Announces Symvess® is Now Under Contract with the Strategic Acquisition Center (SAC) of the U.S. Department of Veterans Affairs https://ml.globenewswire.com/media/e81aff26-ead8-404d-aebb-159b45c3e7b1/small/huma-logo-png.png https://healthylivingeurope.com/article/913835869-phathom-pharmaceuticals-highlights-breadth-of-independent-vonoprazan-research-at-digestive-disease-week-2026-annual-meeting Healthy Living Europe en PressRelease 2026-05-20T12:00:00+00:00 Phathom Pharmaceuticals Highlights Breadth of Independent Vonoprazan Research at Digestive Disease Week 2026 Annual Meeting https://ml.globenewswire.com/media/0baa6f51-c6cb-4b21-a4e0-573a18b8171c/small/phathom-pharm-logo-jpg.jpg https://healthylivingeurope.com/article/913836085-gelteq-commences-veterinary-medicine-clinical-trial-to-support-an-fda-regulatory-pathway Healthy Living Europe en PressRelease 2026-05-20T12:00:00+00:00 Gelteq Commences Veterinary Medicine Clinical Trial to Support an FDA Regulatory Pathway https://ml.globenewswire.com/media/178e1a9c-f21e-4691-add7-b1398d96f7a6/small/gelteq-jpg.jpg https://healthylivingeurope.com/article/913836603-xchange-26-attendee-insights-highlight-healthcare-ai-s-shift-from-adoption-to-operational-scale Healthy Living Europe en PressRelease 2026-05-20T12:00:00+00:00 XCHANGE ‘26 Attendee Insights Highlight Healthcare AI’s Shift From Adoption to Operational Scale https://ml.globenewswire.com/media/71d3851d-9088-40ca-8ef6-3f420e7e3ef5/small/logo-xsolis-horizontal-navy-png.png https://healthylivingeurope.com/article/913836623-prenetics-announces-jay-shetty-as-im8-global-ambassador-and-shareholder-in-multi-year-partnership Healthy Living Europe en PressRelease 2026-05-20T12:00:00+00:00 Prenetics Announces Jay Shetty as IM8 Global Ambassador and Shareholder in Multi-Year Partnership https://ml.globenewswire.com/media/37ffe5e6-4c45-4e12-83bb-cfb9f70307a1/medium/jay-shetty-im8.jpg https://healthylivingeurope.com/article/913836650-annovis-announces-pricing-of-15-0-million-public-offering-of-common-stock-and-accompanying-warrants Healthy Living Europe en PressRelease 2026-05-20T12:00:00+00:00 Annovis Announces Pricing of $15.0 Million Public Offering of Common Stock and Accompanying Warrants https://ml.globenewswire.com/media/7ee459df-d33f-4f42-b27c-3bd20487d50c/small/annovis-corp-image-png.png https://healthylivingeurope.com/article/913836659-dyne-therapeutics-announces-initiation-of-phase-3-forzetto-trial-of-z-rostudirsen-in-duchenne-muscular-dystrophy-dmd-ahead-of-planned-bla-submission Healthy Living Europe en PressRelease 2026-05-20T11:46:18+00:00 Dyne Therapeutics Announces Initiation of Phase 3 FORZETTO Trial of Z-Rostudirsen in Duchenne Muscular Dystrophy (DMD) Ahead of Planned BLA Submission for U.S. Accelerated Approval https://ml.globenewswire.com/media/a9bc6e9f-f2a5-4129-978f-751f41a83728/medium/forzetto.png https://healthylivingeurope.com/article/913835708-lung-health-foundation-says-canada-s-current-access-system-to-emerging-therapies-is-moving-slower-than-modern-medicine Healthy Living Europe en PressRelease 2026-05-20T11:45:00+00:00 Lung Health Foundation Says Canada’s Current Access System to Emerging Therapies is Moving Slower than Modern Medicine https://ml.globenewswire.com/media/58a138ed-9f59-4520-98a9-1e68ebed4f05/small/lhf-primarylogo-rgb-150dpi-002-orig-png.png https://healthylivingeurope.com/article/913836646-jupiter-neurosciences-secures-100m-term-sheet-for-exclusive-u-s-rights-to-ala-002-a-next-generation-mdma-therapeutic-from-pharmala-biotech Healthy Living Europe en PressRelease 2026-05-20T11:38:00+00:00 Jupiter Neurosciences Secures $100M Term Sheet for Exclusive U.S. Rights to ALA-002, a Next-Generation MDMA Therapeutic from PharmAla Biotech https://ml.globenewswire.com/media/4e829d7e-ecf6-46ad-98fe-479755d626e1/small/image-png.png https://healthylivingeurope.com/article/913836034-kraig-biocraft-laboratories-highlights-technical-breakthrough-of-its-immortalized-silk-gland-cell-platform Healthy Living Europe en PressRelease 2026-05-20T11:35:00+00:00 Kraig Biocraft Laboratories Highlights Technical Breakthrough of Its Immortalized Silk Gland Cell Platform https://ml.globenewswire.com/media/c5c0ab91-d30a-423a-b5e9-b4e2ac827c3d/medium/kraig-labs-scientific-team-immortalizes-silk-gland-cell.png https://healthylivingeurope.com/article/913836583-repligen-announces-publication-of-the-company-s-2025-corporate-sustainability-report Healthy Living Europe en PressRelease 2026-05-20T11:30:00+00:00 Repligen Announces Publication of the Company’s 2025 Corporate Sustainability Report https://ml.globenewswire.com/media/967d43f6-7ffd-4ee0-8804-e3c12952402f/small/repligen-logo-horizontal-withtagline-1-jpg.jpg https://healthylivingeurope.com/article/913836635-emergent-biosolutions-to-participate-in-upcoming-investor-conferences Healthy Living Europe en PressRelease 2026-05-20T11:30:00+00:00 Emergent BioSolutions to Participate in Upcoming Investor Conferences https://ml.globenewswire.com/media/56a9097d-af91-4bcf-8c42-5905e1614ef1/small/emerge-png.png https://healthylivingeurope.com/article/913836601-medline-inc-announces-launch-of-secondary-offering-of-class-a-common-stock Healthy Living Europe en PressRelease 2026-05-20T11:10:41+00:00 Medline Inc. announces launch of secondary offering of Class A common stock https://ml.globenewswire.com/media/70e45830-32e3-4232-b15b-7e43c436de41/small/log-medline-1200-630-center-png.png https://healthylivingeurope.com/article/913834361-4basebio-signs-clinical-supply-agreement-to-support-phase-ii-clinical-trial Healthy Living Europe en PressRelease 2026-05-20T11:00:00+00:00 4basebio Signs Clinical Supply Agreement to Support Phase II Clinical Trial https://ml-eu.globenewswire.com/media/b4cdfb28-5792-4f0a-b80f-b960556fe025/small/4basebio-logo-1-png.png https://healthylivingeurope.com/article/913834365-final-results-and-notice-of-agm Healthy Living Europe en PressRelease 2026-05-20T11:00:00+00:00 Final Results and Notice of AGM https://ml-eu.globenewswire.com/media/b4cdfb28-5792-4f0a-b80f-b960556fe025/small/4basebio-logo-1-png.png https://healthylivingeurope.com/article/913834601-syndax-announces-participation-in-upcoming-investor-conferences Healthy Living Europe en PressRelease 2026-05-20T11:00:00+00:00 Syndax Announces Participation in Upcoming Investor Conferences https://ml.globenewswire.com/media/399a65b5-bd4f-4ba5-980b-f4d0af9ae6a0/small/syndax-logo-jpg.jpg https://healthylivingeurope.com/article/913834766-why-biotech-companies-are-replacing-national-gas-suppliers-with-agile-regional-partners-in-2026 Healthy Living Europe en PressRelease 2026-05-20T11:00:00+00:00 Why Biotech Companies Are Replacing National Gas Suppliers With Agile Regional Partners in 2026 https://ml.globenewswire.com/media/54f68786-45fe-483a-944a-10d2ef6d7baf/small/westair-logo-png.png https://healthylivingeurope.com/article/913834799-monte-rosa-therapeutics-to-participate-in-upcoming-investor-conferences Healthy Living Europe en PressRelease 2026-05-20T11:00:00+00:00 Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences https://ml.globenewswire.com/media/20ed9999-454a-4e2a-aabc-217270a87d2d/small/mrtx-logo-primaryblue-4cp-jpg.jpg https://healthylivingeurope.com/article/913835070-netramark-to-present-at-the-american-society-of-clinical-psychopharmacology-annual-meeting Healthy Living Europe en PressRelease 2026-05-20T11:00:00+00:00 NetraMark to Present at the American Society of Clinical Psychopharmacology Annual Meeting https://ml.globenewswire.com/media/d65cf3f8-cf9c-475c-b740-09a659269da4/small/netramark-word-eye-blk-jpg.jpg https://healthylivingeurope.com/article/913835195-ichnos-glenmark-innovation-igi-announces-new-development-candidate-isb-2301-a-first-in-class-multispecific-immune-cells-activator-targeting-solid Healthy Living Europe en PressRelease 2026-05-20T11:00:00+00:00 Ichnos Glenmark Innovation (IGI) Announces New Development Candidate, ISB 2301, a First-in-Class Multispecific Immune Cells Activator Targeting Solid Tumors https://ml.globenewswire.com/media/1efc56d9-10ca-47f6-b389-0f549311aa9e/small/igi-ichnos-glenmark-innovation-logo-png.png https://healthylivingeurope.com/article/913835355-c4-therapeutics-to-participate-in-upcoming-conferences Healthy Living Europe en PressRelease 2026-05-20T11:00:00+00:00 C4 Therapeutics to Participate in Upcoming Conferences https://ml.globenewswire.com/media/50045422-c7cb-42b0-857a-1f69f1efc0a6/small/c4therapeutics-website-logo-fullcolor-r-png.png https://healthylivingeurope.com/article/913835910-blossomhill-therapeutics-expands-board-of-directors-with-the-appointments-of-sheila-gujrathi-m-d-and-john-schmid Healthy Living Europe en PressRelease 2026-05-20T11:00:00+00:00 BlossomHill Therapeutics Expands Board of Directors with the Appointments of Sheila Gujrathi, M.D., and John Schmid  https://ml.globenewswire.com/media/02f747e9-636d-467e-81f8-d942e9421158/small/blossomhill-vertical-fullcolor-cmyk1-jpg.jpg https://healthylivingeurope.com/article/913836003-skye-announces-cohort-review-committee-approved-opening-of-cohort-2-based-on-favorable-safety-data-from-first-four-participants-treated-in-cohort-1 Healthy Living Europe en PressRelease 2026-05-20T11:00:00+00:00 Skye Announces Cohort Review Committee Approved Opening of Cohort 2 Based on Favorable Safety Data from First Four Participants Treated in Cohort 1 https://ml.globenewswire.com/media/905e06d8-af43-4f7a-b097-8c12ce1d3aa0/small/skye-darkblue-jpg.jpg https://healthylivingeurope.com/article/913836053-immunovant-provides-corporate-updates-and-reports-financial-results-for-the-fourth-quarter-and-fiscal-year-ended-march-31-2026 Healthy Living Europe en PressRelease 2026-05-20T11:00:00+00:00 Immunovant Provides Corporate Updates and Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2026 https://ml.globenewswire.com/media/7062c765-82cc-4ba2-ba1f-4b1396b9b052/small/immulogo-jpg.jpg https://healthylivingeurope.com/article/913836056-roivant-reports-financial-results-for-the-fourth-quarter-and-fiscal-year-ended-march-31-2026-and-provides-business-update Healthy Living Europe en PressRelease 2026-05-20T11:00:00+00:00 Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2026 and Provides Business Update https://ml.globenewswire.com/media/f1a5db68-ee4f-437f-b4e6-2b840ae6a536/small/roivantlogo-png.png https://healthylivingeurope.com/article/913836438-zoomrx-launches-sagan-agents-the-ai-operating-system-purpose-built-to-agentify-any-pharma-customer-insights-workflow Healthy Living Europe en PressRelease 2026-05-20T11:00:00+00:00 ZoomRx launches Sagan Agents, the AI operating system purpose-built to agentify any pharma customer insights workflow https://ml.globenewswire.com/media/d4f29735-65dd-4876-bb74-39e063c64fcc/small/sagan-agents-black-png.png https://healthylivingeurope.com/article/913836546-grey-matters-health-signs-loi-with-catalyst-medtech-for-200-brain-pet-scans-for-alzheimer-s-clinical-trial-at-2nd-novascan-location-planned-for-tampa Healthy Living Europe en PressRelease 2026-05-20T11:00:00+00:00 Grey Matters Health Signs LOI with Catalyst MedTech for 200 Brain PET Scans for Alzheimer’s Clinical Trial at 2nd NovaScan Location Planned for Tampa https://ml.globenewswire.com/media/fa49f075-8db6-4fbc-b1da-8e710a9d4235/medium/novascan-neuroimaging-clinics.jpg https://healthylivingeurope.com/article/913835915-avricore-health-announces-1-25-million-financing Healthy Living Europe en PressRelease 2026-05-20T10:55:00+00:00 Avricore Health Announces $1.25 Million Financing https://ml.globenewswire.com/media/a3e47a88-fedc-4db4-969f-5fe1f028c54a/small/avicorelogo-png.png https://healthylivingeurope.com/article/913810443-un-essai-clinique-canadien-sans-pr-c-dent-value-des-comprim-s-de-selles-pour-am-liorer-l-immunoth-rapie-du-cancer-du-poumon Healthy Living Europe en PressRelease 2026-05-20T10:34:25+00:00 Un essai clinique canadien sans précédent évalue des « comprimés de selles » pour améliorer l’immunothérapie du cancer du poumon https://ml.globenewswire.com/media/MDcyMzc5OWYtNGRlMi00NmY0LWI0MTUtYTI3YTkzZmRhNmEzLTUwMDExMzcxNy0yMDI2LTA1LTIwLWZy/tiny/Weston-Family-Foundation.png https://healthylivingeurope.com/article/913810467-largest-ever-canadian-clinical-trial-tests-poop-pills-to-improve-immunotherapy-for-lung-cancer Healthy Living Europe en PressRelease 2026-05-20T10:34:25+00:00 Largest-ever Canadian clinical trial tests “poop pills” to improve immunotherapy for lung cancer https://ml.globenewswire.com/media/NzUyMTIxM2YtMTdiNC00NTk3LTg5MjktMTIyM2EwYzMzNzRhLTUwMDExMzcxNy0yMDI2LTA1LTIwLWVu/tiny/Weston-Family-Foundation.png https://healthylivingeurope.com/article/913810224-pacira-biosciences-files-investor-presentation-highlighting-successful-execution-of-its-long-term-strategy-to-drive-value-for-all-stockholders Healthy Living Europe en PressRelease 2026-05-20T10:30:00+00:00 Pacira BioSciences Files Investor Presentation Highlighting Successful Execution of its Long-Term Strategy to Drive Value for All Stockholders https://ml.globenewswire.com/media/3e502c92-e576-46b6-b602-a177ab0f5044/small/pacira-biosciences-tm-logo-rgb-v2025-300dpi-adj-png.png https://healthylivingeurope.com/article/913810286-corvel-announces-revenues-and-earnings Healthy Living Europe en PressRelease 2026-05-20T10:15:00+00:00 CorVel Announces Revenues and Earnings https://ml.globenewswire.com/media/dc150059-2d36-47de-9f10-e6f5990ba046/small/corvel-primary-full-color-png.png https://healthylivingeurope.com/article/913810300-belite-bio-reports-unaudited-first-quarter-2026-financial-results-and-provides-a-corporate-update Healthy Living Europe en PressRelease 2026-05-20T10:00:00+00:00 Belite Bio Reports Unaudited First Quarter 2026 Financial Results and Provides a Corporate Update https://ml.globenewswire.com/media/7f86ac70-6347-41c6-a622-e7000c42ad35/small/belite-bio-logo-digital-full-color-png.png https://healthylivingeurope.com/article/913810423-hiwell-absorfyx-berberine-with-ceylon-cinnamon-a-modern-approach-to-daily-metabolic-wellness-and-weight-management-support Healthy Living Europe en PressRelease 2026-05-20T09:37:54+00:00 HiWell Absorfyx Berberine with Ceylon Cinnamon: A Modern Approach to Daily Metabolic Wellness and Weight Management Support https://ml.globenewswire.com/media/12bc8091-fb3e-4454-bd78-437710efb91a/medium/hiwell-absorfyx-formula-per-2-capsules-berberine-300mg-ceylo.png https://healthylivingeurope.com/article/913810336-winner-medical-breaks-ground-on-new-production-base-in-vietnam-to-serve-global-medical-supply-chains-through-local-manufacturing Healthy Living Europe en PressRelease 2026-05-20T08:28:38+00:00 Winner Medical Breaks Ground on New Production Base in Vietnam to Serve Global Medical Supply Chains Through Local Manufacturing https://ml.globenewswire.com/media/0b41efe6-06e6-46af-b13f-c2d26d36d16d/medium/image-1.jpeg https://healthylivingeurope.com/article/913674279-industrial-wi-fi-7-module-converges-long-range-ble-sensing-and-aux-radio-for-physical-ai-airetos-c27-from-voxmicro Healthy Living Europe en PressRelease 2026-05-19T20:07:22+00:00 Industrial Wi-Fi 7 Module Converges Long-Range BLE, Sensing, and Aux Radio for Physical AI — AIRETOS C27 from VOXMICRO https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24861428-c27-wi-fi-module-for-the-physic-1200x628.png https://healthylivingeurope.com/article/913637593-unchainedtv-wins-19-telly-awards-in-a-victory-for-vegan-tv-programming Healthy Living Europe en PressRelease 2026-05-19T19:50:52+00:00 UnchainedTV Wins 19 Telly Awards in a Victory for Vegan TV Programming https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24861265-new-day-new-chef-lite-telly-a-1920x1080.jpeg https://healthylivingeurope.com/article/913788145-serb-pharmaceuticals-erwirbt-von-hansa-biopharma-europ-ische-und-mena-rechte-an-idefirix-imlifidase-f-r-115-mio Healthy Living Europe en PressRelease 2026-05-20T05:51:38+00:00 SERB Pharmaceuticals erwirbt von Hansa Biopharma europäische und MENA-Rechte an Idefirix® (Imlifidase) für 115 Mio. € https://ml.globenewswire.com/media/NGY2ZjhiYTAtYjMyMS00M2E4LWI2ODUtZjE5YmNiMTk5YTlhLTUwMDE1NTM3MC0yMDI2LTA1LTIwLWRl/tiny/SERB-Pharmaceuticals.png https://healthylivingeurope.com/article/913788153-serb-pharmaceuticals-acquiert-aupr-s-de-hansa-biopharma-les-droits-europ-ens-et-mena-d-idefirix-imlifidase-pour-115-millions-d-euros Healthy Living Europe en PressRelease 2026-05-20T05:51:38+00:00 SERB Pharmaceuticals acquiert auprès de Hansa Biopharma les droits européens et MENA d’Idefirix® (imlifidase) pour 115 millions d’euros https://ml.globenewswire.com/media/NGY2ZjhiYTAtYjMyMS00M2E4LWI2ODUtZjE5YmNiMTk5YTlhLTUwMDE1NTM3MC0yMDI2LTA1LTIwLWZy/tiny/SERB-Pharmaceuticals.png https://healthylivingeurope.com/article/913767210-synendos-therapeutics-starts-phase-2-trial-in-generalized-anxiety-disorder Healthy Living Europe en PressRelease 2026-05-20T05:30:00+00:00 Synendos Therapeutics Starts Phase 2 Trial in Generalized Anxiety Disorder https://ml-eu.globenewswire.com/media/9a6e58ee-f37d-4ff6-ba7b-3296827b2348/medium/professor-allan-young.png https://healthylivingeurope.com/article/913650221-how-dr-nina-kottler-told-sanjay-puri-on-the-caio-connect-podcast-that-ai-will-redefine-radiology Healthy Living Europe en PressRelease 2026-05-19T17:18:11+00:00 How Dr. Nina Kottler Told Sanjay Puri on the CAIO Connect Podcast That AI Will Redefine Radiology https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/23846351-caio-connect-podcast-1500x600.jpeg https://healthylivingeurope.com/article/912850726-cambridge-derived-brain-health-company-prema-cognition-closes-funding-round-to-advance-early-dementia-detection Healthy Living Europe en PressRelease 2026-05-19T17:16:21+00:00 Cambridge-derived brain health company Prema Cognition closes funding round to advance early dementia detection https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24857261-new-logo-premaz-prema-cogni-1920x1080.png https://healthylivingeurope.com/article/913649221-studyfetch-launches-honen-for-enterprise-an-agentic-learning-platform-that-builds-training-in-minutes Healthy Living Europe en PressRelease 2026-05-19T17:12:47+00:00 StudyFetch Launches Honen for Enterprise: An Agentic Learning Platform That Builds Training in Minutes https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24861181-honen-logo-1600x836.jpeg https://healthylivingeurope.com/article/913633220-bentonville-welcomes-new-sgs-bicycle-emobility-transit-packaging-testing-lab-supporting-community-cycling-initiatives Healthy Living Europe en PressRelease 2026-05-19T15:48:14+00:00 Bentonville Welcomes New Sgs Bicycle Emobility & Transit Packaging Testing Lab, Supporting Community Cycling Initiatives https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24861007-sgs-ribbon-4096x2926.jpeg https://healthylivingeurope.com/article/913059653-nubrain-previews-human-mind-api-to-turn-thoughts-into-action Healthy Living Europe en PressRelease 2026-05-19T14:00:00+00:00 Nubrain Previews Human Mind API to Turn Thoughts into Action https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24858238-nubrain-logo-1127x256.png https://healthylivingeurope.com/article/913619222-funded-uk-relaunches-as-bahri-bahri-signalling-a-new-era-for-r-d-tax-relief-advisory Healthy Living Europe en PressRelease 2026-05-19T13:56:03+00:00 Funded UK Relaunches as Bahri & Bahri, Signalling a New Era for R&D Tax Relief Advisory https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24860905-website-1852x843.jpeg https://healthylivingeurope.com/article/913494196-sciensus-and-disc-medicine-demonstrate-scalable-multinational-rare-disease-survey-framework-at-ispor-2026 Healthy Living Europe en PressRelease 2026-05-19T13:56:01+00:00 Sciensus and Disc Medicine demonstrate scalable multinational rare disease survey framework at ISPOR 2026 https://healthylivingeurope.com/article/913344094-syndevrx-to-present-amelia-1-data-at-asco-2026-showing-improved-pi3k-akt-class-inhibitor-responses-in-breast-cancer Healthy Living Europe en PressRelease 2026-05-19T13:30:00+00:00 SynDevRx to Present AMELIA™-1 Data at ASCO 2026 Showing Improved PI3K/AKT Class Inhibitor Responses in Breast Cancer https://healthylivingeurope.com/article/913742811-shiny-smile-veneers-claims-evaluated-2026-consumer-report-update-critical-complaints-investigated Healthy Living Europe en PressRelease 2026-05-20T01:23:45+00:00 Shiny Smile Veneers Claims Evaluated (2026 Consumer Report Update) Critical Complaints Investigated https://zingfast.com/wp-content/uploads/2026/05/Shiny-Smile-Veneers-Complaints.jpg https://healthylivingeurope.com/article/913742796-java-tide-critical-assessment-the-gelatin-ice-trick-before-bed-using-the-java-tide-formula-recipe Healthy Living Europe en PressRelease 2026-05-20T01:04:03+00:00 Java Tide Critical Assessment: The Gelatin Ice Trick Before Bed Using the Java Tide Formula Recipe https://zingfast.com/wp-content/uploads/2026/05/Java-Tide-2.jpg https://healthylivingeurope.com/article/913030082-core-biogenesis-wins-c-t-all-award-for-peauvita-innovation Healthy Living Europe en PressRelease 2026-05-19T13:00:00+00:00 Core Biogenesis Wins C&T Allē Award for Peauvita™ Innovation https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24860772-core-biogenesis-wins-cosmetics-1520x1600.jpeg https://healthylivingeurope.com/article/913413950-todd-crandell-9-time-author-and-recovery-advocate-set-to-complete-ironman-events-132-and-133 Healthy Living Europe en PressRelease 2026-05-19T13:00:00+00:00 Todd Crandell, 9-Time Author and Recovery Advocate, Set to Complete IRONMAN Events #132 and #133 https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24859367-achievement-2139x3200.jpeg https://healthylivingeurope.com/article/913587893-the-market-demand-for-ribonucleic-acid-rna-splicing-modulators-is-projected-to-grow-to-us-5-68-billion-by-2030 Healthy Living Europe en PressRelease 2026-05-19T12:54:10+00:00 The market demand for Ribonucleic Acid (RNA) Splicing Modulators is projected to grow to US $5.68 billion by 2030. https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://healthylivingeurope.com/article/913587041-the-reverse-transcription-kits-market-is-projected-to-grow-to-2-5-billion-by-2030 Healthy Living Europe en PressRelease 2026-05-19T12:54:09+00:00 The Reverse Transcription Kits Market is Projected to Grow to $2.5 Billion by 2030 https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://healthylivingeurope.com/article/913583608-non-medical-grade-aesthetic-device-market-to-grow-at-8-8-cagr-during-2026-2030-reaching-15-12-billion-by-2030 Healthy Living Europe en PressRelease 2026-05-19T12:54:08+00:00 Non-Medical Grade Aesthetic Device Market to Grow at 8.8% CAGR During 2026–2030, Reaching $15.12 Billion by 2030 https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://healthylivingeurope.com/article/913565076-pooled-crispr-screening-market-analysis-of-opportunities-market-share-growth-competition-and-forecast-through-2030 Healthy Living Europe en PressRelease 2026-05-19T12:54:06+00:00 Pooled CRISPR Screening Market - Analysis of Opportunities, Market Share, Growth, Competition, and Forecast through 2030 https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://healthylivingeurope.com/article/913568508-in-depth-analysis-of-the-respiratory-viral-load-quantification-market-key-opportunities-and-challenges Healthy Living Europe en PressRelease 2026-05-19T12:53:11+00:00 In-Depth Analysis of the Respiratory Viral Load Quantification Market: Key Opportunities and Challenges https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://healthylivingeurope.com/article/913567408-the-rapid-molecular-flu-testing-platforms-market-is-projected-to-grow-to-4-46-bn-by-2030-expanding-at-a-cagr-of-10-6 Healthy Living Europe en PressRelease 2026-05-19T12:53:08+00:00 The Rapid Molecular Flu Testing Platforms Market is projected to grow to $4.46 Bn by 2030, expanding at a CAGR of 10.6% https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://healthylivingeurope.com/article/913567010-in-depth-analysis-of-the-protein-folding-artificial-intelligence-ai-platform-market-key-opportunities-and-challenges Healthy Living Europe en PressRelease 2026-05-19T12:53:07+00:00 In-Depth Analysis of the Protein-Folding Artificial Intelligence (AI) Platform Market: Key Opportunities and Challenges https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://healthylivingeurope.com/article/913564261-personalized-ctdna-fingerprint-panels-market-2030-growth-drivers-trends-expansion-competitive-insights Healthy Living Europe en PressRelease 2026-05-19T12:53:01+00:00 Personalized ctDNA Fingerprint Panels Market 2030: Growth Drivers, Trends, Expansion & Competitive Insights https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://healthylivingeurope.com/article/913563974-the-pathogen-air-monitoring-market-is-projected-to-grow-to-2-18-billion-by-2030 Healthy Living Europe en PressRelease 2026-05-19T12:52:58+00:00 The Pathogen Air Monitoring Market is projected to grow to $2.18 billion by 2030 https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://healthylivingeurope.com/article/913560044-pharmaceutical-supply-chain-integrity-market-to-hit-usd-6-42b-by-2030-growing-at-a-9-9-cagr Healthy Living Europe en PressRelease 2026-05-19T12:52:36+00:00 Pharmaceutical Supply Chain Integrity Market to hit USD 6.42B by 2030, growing at a 9.9% CAGR. https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://healthylivingeurope.com/article/913558653-oncology-treatment-tourism-market-analysis-of-future-demand-and-leading-key-players-by-2030 Healthy Living Europe en PressRelease 2026-05-19T12:52:33+00:00 Oncology Treatment Tourism Market: Analysis of Future Demand and Leading Key Players by 2030 https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://healthylivingeurope.com/article/913608008-thrive-buildings-partners-with-cpower-to-bring-safe-scalable-demand-management-to-critical-environments Healthy Living Europe en PressRelease 2026-05-19T12:36:55+00:00 Thrive Buildings Partners with CPower to Bring Safe, Scalable Demand Management to Critical Environments https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24860851-demand-response-event-305x100.png https://healthylivingeurope.com/article/913510757-data-from-immunophotonics-phase-1b-2a-clinical-trial-to-be-presented-at-asco-2026 Healthy Living Europe en PressRelease 2026-05-19T12:15:00+00:00 Data from Immunophotonics Phase 1b/2a Clinical Trial to Be Presented at ASCO 2026 https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/5902492-logo-2400x776.png https://healthylivingeurope.com/article/913393191-scw-ai-and-simtra-biopharma-solutions-announce-co-innovation-partnership-for-digital-factory-transformation Healthy Living Europe en PressRelease 2026-05-19T12:07:54+00:00 SCW.AI and Simtra BioPharma Solutions Announce Co-Innovation Partnership for Digital Factory Transformation https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24859383-scw-ai-x-simtra-biopharma-solut-2400x1256.png https://healthylivingeurope.com/article/913718020-slimtide-claims-evaluated-the-baking-soda-water-shot-gelatin-trick-for-losing-weight-naturally-by-slim-tide Healthy Living Europe en PressRelease 2026-05-19T23:59:41+00:00 SlimTide Claims Evaluated: The Baking Soda Water Shot Gelatin Trick for Losing Weight Naturally by Slim Tide https://zingfast.com/wp-content/uploads/2026/05/SlimTide-1.jpg https://healthylivingeurope.com/article/913694193-monopar-announces-publication-of-phase-2-study-demonstrating-alxn1840-significantly-improves-copper-balance-in-patients-with-wilson-disease Healthy Living Europe en PressRelease 2026-05-19T21:33:00+00:00 Monopar Announces Publication of Phase 2 Study Demonstrating ALXN1840 Significantly Improves Copper Balance in Patients with Wilson Disease https://ml.globenewswire.com/media/f8cee181-5ae9-4a02-84f5-6e35affbb72b/small/monopartherapeuticsinc-png.png https://healthylivingeurope.com/article/913693831-aura-biosciences-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Healthy Living Europe en PressRelease 2026-05-19T20:50:52+00:00 Aura Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/92103c30-8e5a-4502-9ec4-0f3b3bd9bb83/small/aura-biosciences-1c-orange-large-jpg.jpg https://healthylivingeurope.com/article/913693815-journey-medical-corporation-to-participate-in-a-g-p-s-annual-virtual-healthcare-conference Healthy Living Europe en PressRelease 2026-05-19T20:45:00+00:00 Journey Medical Corporation to Participate in A.G.P.’s Annual Virtual Healthcare Conference https://ml.globenewswire.com/media/68f0b467-248f-4250-9cda-2c7a68a11a1d/small/journeylogo-1-jpg.jpg https://healthylivingeurope.com/article/913693217-olema-oncology-to-participate-in-upcoming-investor-conferences Healthy Living Europe en PressRelease 2026-05-19T20:30:00+00:00 Olema Oncology to Participate in Upcoming Investor Conferences https://ml.globenewswire.com/media/9c736753-c905-4bd1-ac3a-1444bea84331/small/olema-logo-rgb-png.png https://healthylivingeurope.com/article/913693284-eton-pharmaceuticals-expands-rare-disease-portfolio-through-agreement-for-u-s-commercialization-rights-to-impavido-miltefosine Healthy Living Europe en PressRelease 2026-05-19T20:30:00+00:00 Eton Pharmaceuticals Expands Rare Disease Portfolio Through Agreement for U.S. Commercialization Rights to IMPAVIDO® (miltefosine) https://ml.globenewswire.com/media/db07cafa-b35c-4d61-a1a1-d330caf67ad2/small/eton-logo-png.png https://healthylivingeurope.com/article/913693608-cadrenal-therapeutics-to-participate-in-the-lytham-partners-spring-2026-investor-conference-on-may-28-2026 Healthy Living Europe en PressRelease 2026-05-19T20:30:00+00:00 Cadrenal Therapeutics to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026 https://ml.globenewswire.com/media/dec0fe5d-b262-4ca7-94e0-1fd3856d07a8/small/cvkd-logo-2025-png.png https://healthylivingeurope.com/article/913693704-ozari-health-launches-nationwide-telehealth-platform-for-compounded-semaglutide-and-tirzepatide-starting-at-86-per-month Healthy Living Europe en PressRelease 2026-05-19T20:15:00+00:00 Ozari Health Launches Nationwide Telehealth Platform for Compounded Semaglutide and Tirzepatide Starting at $86 Per Month https://pressranger.s3.us-west-1.amazonaws.com/3292406/Untitled-design-%283%29.png https://healthylivingeurope.com/article/913693269-rxsight-inc-to-present-at-the-stifel-2026-virtual-ophthalmology-forum Healthy Living Europe en PressRelease 2026-05-19T20:10:00+00:00 RxSight, Inc. to Present at the Stifel 2026 Virtual Ophthalmology Forum https://ml.globenewswire.com/media/48441335-c938-45ff-9355-ba8e331354e9/small/rxsight-globe-png.png https://healthylivingeurope.com/article/913693728-annovis-announces-launch-of-proposed-public-offering-of-common-stock-and-accompanying-warrants Healthy Living Europe en PressRelease 2026-05-19T20:06:26+00:00 Annovis Announces Launch of Proposed Public Offering of Common Stock and Accompanying Warrants https://ml.globenewswire.com/media/7ee459df-d33f-4f42-b27c-3bd20487d50c/small/annovis-corp-image-png.png https://healthylivingeurope.com/article/913693193-alps-group-inc-announces-receipt-of-nasdaq-notification-regarding-minimum-bid-price-deficiency Healthy Living Europe en PressRelease 2026-05-19T20:05:00+00:00 Alps Group Inc Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency https://ml.globenewswire.com/media/ce232220-dc3f-4308-a2b7-f695be7b9f0b/small/alps-global-holding-berhad-logo-01-png.png https://healthylivingeurope.com/article/913693214-iridex-reports-first-quarter-2026-financial-results Healthy Living Europe en PressRelease 2026-05-19T20:05:00+00:00 Iridex Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/2bb80159-a920-428b-aa69-c2f32e3038c9/small/iridex-corporate-logo-horizontal-rgb-m02-jpg.jpg https://healthylivingeurope.com/article/913693273-resmed-announces-participation-in-the-46th-annual-william-blair-growth-stock-conference Healthy Living Europe en PressRelease 2026-05-19T20:05:00+00:00 Resmed Announces Participation in the 46th Annual William Blair Growth Stock Conference https://ml.globenewswire.com/media/fb7a34f4-d074-4bcf-b827-7a6a60924c46/small/resmed-h-pos-clr-rgb-250121-png.png https://healthylivingeurope.com/article/913693277-suja-life-to-report-first-quarter-2026-financial-results-on-june-9-2026 Healthy Living Europe en PressRelease 2026-05-19T20:05:00+00:00 Suja Life to Report First Quarter 2026 Financial Results on June 9, 2026 https://ml.globenewswire.com/media/9022887d-dd69-416f-9a4b-ce5e546d75e4/small/suja-life-horizontal-black-1-png.png https://healthylivingeurope.com/article/913693488-artiva-biotherapeutics-announces-multiple-allonk-data-presentations-at-eular-2026-congress-including-late-breaking-oral-presentation-highlighting Healthy Living Europe en PressRelease 2026-05-19T20:05:00+00:00 Artiva Biotherapeutics Announces Multiple AlloNK® Data Presentations at EULAR 2026 Congress, Including Late-Breaking Oral Presentation Highlighting Clinical Efficacy Comparable to Autologous CAR T-Cell Therapy in Rheumatologic Diseases https://ml.globenewswire.com/media/0392544b-ecff-4590-9eed-59c934e1ba4d/small/artiva-biotherapeutics-logo-jpg.jpg https://healthylivingeurope.com/article/913693615-nurexone-receives-notice-of-patent-grant-in-south-korea-covering-exopten-technology Healthy Living Europe en PressRelease 2026-05-19T20:04:00+00:00 NurExone Receives Notice of Patent Grant in South Korea Covering ExoPTEN Technology https://ml.globenewswire.com/media/1514c671-cc84-4bcb-82d7-b834fce40882/small/nurexone-logo-rebrand-large-png.png https://healthylivingeurope.com/article/913693629-relay-therapeutics-announces-proposed-public-offering-of-common-stock Healthy Living Europe en PressRelease 2026-05-19T20:03:00+00:00 Relay Therapeutics Announces Proposed Public Offering of Common Stock https://ml.globenewswire.com/media/079b6db5-ce81-4a81-9cde-d97f86c569ae/small/logo-banner-small-png.png https://healthylivingeurope.com/article/913693235-kura-oncology-to-present-at-td-cowen-7th-annual-oncology-innovation-summit Healthy Living Europe en PressRelease 2026-05-19T20:02:00+00:00 Kura Oncology to Present at TD Cowen 7th Annual Oncology Innovation Summit https://ml.globenewswire.com/media/ebf510d7-3727-4cc8-894f-6ce2d82b941a/small/kura-logo-for-globe-newswire-prs-png.png https://healthylivingeurope.com/article/913693696-vaxart-files-preliminary-proxy-statement-and-issues-open-letter-to-shareholders Healthy Living Europe en PressRelease 2026-05-19T20:01:00+00:00 Vaxart Files Preliminary Proxy Statement and Issues Open Letter to Shareholders https://ml.globenewswire.com/media/aedaf06c-26f8-482c-ac72-39774eab2c35/small/vxrt-logo-jpg.png https://healthylivingeurope.com/article/913693594-sol-sence-day-mode-hero-concealer-spf-50-wins-three-categories-at-the-2026-cosmetics-toiletries-all-awards-marking-fourth-year-of-recognition Healthy Living Europe en PressRelease 2026-05-19T19:31:49+00:00 Solésence Day Mode Hero Concealer SPF 50+ Wins Three Categories at the 2026 Cosmetics & Toiletries Allē Awards, Marking Fourth Year of Recognition https://ml.globenewswire.com/media/cd3e5e4e-9567-4a86-8f44-900ffeb29d33/small/solesence-fullcolor-300dpi-social-002-1-png.png https://healthylivingeurope.com/article/913669891-ipsen-announces-late-breaking-data-from-first-head-to-head-study-comparing-dysport-and-botox-in-adults-with-upper-limb-spasticity Healthy Living Europe en PressRelease 2026-05-19T19:00:00+00:00 Ipsen announces late-breaking data from first head-to-head study comparing Dysport® and Botox® in adults with upper limb spasticity https://ml-eu.globenewswire.com/media/81292fcc-6b3a-4e4a-a083-ea4191bf920a/small/ipsen-notified-website-1200x628pix-500kb-max-jpg.jpg https://healthylivingeurope.com/article/913669898-ipsen-annonce-des-donn-es-late-breaking-issues-de-la-premi-re-tude-comparative-directe-entre-dysport-et-botox-chez-des-adultes-atteints-de Healthy Living Europe en PressRelease 2026-05-19T19:00:00+00:00 Ipsen annonce des données « late-breaking » issues de la première étude comparative directe entre Dysport® et Botox® chez des adultes atteints de spasticité du membre supérieur https://ml-eu.globenewswire.com/media/81292fcc-6b3a-4e4a-a083-ea4191bf920a/small/